Skip to main content
UniHealth

Doctor search

Erika Schillinger

Family Practice · Stanford

NPI 1578605523

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Office
1

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Erika Schillinger’s office at (650) 723-4000 to ask if they take your plan before you enroll.

California Medical Board record

Licence A55883 · Current

Licensed to practise in California · since 1996 · expires 2027-09-30 · Stanford University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$6,054

Medicare paid this office $6,054 for 60 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Return visit (30+ min)26$1,829$59
Return visit (30+ min)13$1,730$75
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit21$1,357$65

Who their Medicare patients are

60 Original Medicare patients in 2024. Average age 74 · Women 77% · Also on Medicaid 28% · Health risk score 1.13. At or below the middle of the specialty; the typical family practice clinician is at 1.13.

Conditions among them: High blood pressure 57% · Diabetes 28% · Coronary heart disease 25% · Chronic kidney disease 20% · Cancer 18%.

The office billed $42,425, Medicare allowed $8,862 and paid $6,054; for 96 services of 6 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20246096741.13$42,425$6,054
20234775750.94$32,278$4,039
20224470730.92$35,871$4,156
20214366731.25$34,821$4,610
20205281731.23$28,654$5,617
20194970731.29$11,685$5,112
20183462740.96$13,929$4,935
20173660700.74$15,317$4,451
20163666730.84$15,912$4,493
20153249710.99$12,488$3,570
20143149710.97$9,062$2,990
20133982700.83$24,179$6,333

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 2 services

Original Medicare services billed in 2023
Return visit (30+ min)28$2,185$52
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit16$990$62

2022: 2 services

Original Medicare services billed in 2022
Return visit (30+ min)28$2,505$60
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit18$1,098$61

2021: 2 services

Original Medicare services billed in 2021
Return visit (30+ min)25$2,108$64
Long return visit (40+ min)11$880$73

2020: 2 services

Original Medicare services billed in 2020
Return visit (30+ min)30$3,206$70
Short return visit (20+ min)14$562$35

2019: 1 service

Original Medicare services billed in 2019
Return visit (30+ min)37$3,516$68

2018: 1 service

Original Medicare services billed in 2018
Return visit (30+ min)15$1,978$58

2017: 2 services

Original Medicare services billed in 2017
Return visit (30+ min)22$2,539$62
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit11$1,524$139

2016: 1 service

Original Medicare services billed in 2016
Return visit (30+ min)27$3,012$59

2015: 1 service

Original Medicare services billed in 2015
Return visit (30+ min)23$2,066$61

2014: 1 service

Original Medicare services billed in 2014
Return visit (30+ min)27$2,378$63

2013: 1 service

Original Medicare services billed in 2013
Return visit (30+ min)26$3,649$62

Drugs they prescribed that Part D paid

$9,147

Pharmacies billed $9,147 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 9% of their Part D prescriptions (21 of 225) in 2024. A higher opioid share than 9 in 10 peers; the typical family practice clinician is at 2%.

201 generic and 24 brand-name prescriptions · $9,147 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Amlodipine Besylate16$302$19
Promethazine14$256$18
Atorvastatin16$235$15
Levothyroxine14$176$13
Oxycodone11$175$16

Year by year

Part D prescribing by year
2024225409% (21)11%$9,147
2023231385% (11)7%$9,407
2022342666% (21)13%$26,298
2021338724% (13)None$15,945
2020327665% (17)9%$14,816
2019332444% (13)None$22,282
2018365463% (12)None$22,261
2017365634% (16)None$13,334
2016342384% (12)19%$21,602
2015296396% (19)20%$24,200
2014288394% (12)None$11,629
2013384428% (29)None$20,258

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 4 drugs

Part D drugs prescribed in 2023
Atorvastatin20$525$26
Amlodipine Besylate13$305$23
Levothyroxine19$261$14
Benazepril16$236$15

2022: 7 drugs

Part D drugs prescribed in 2022
Potassium Chloride11$435$40
Levothyroxine25$329$13
Gabapentin17$323$19
Atorvastatin24$260$11
Promethazine18$249$14
Amlodipine Besylate19$128$7
Hydrochlorothiazide11$52$5

2021: 11 drugs

Part D drugs prescribed in 2021
Bupropion Xl21$482$23
Levothyroxine23$419$18
Potassium Chloride11$343$31
Atorvastatin22$320$15
Amlodipine Besylate30$237$8
Tamsulosin11$176$16
Methadone11$165$15
Lisinopril13$145$11
Pramipexole Dihydrochloride14$129$9
Fluticasone Propionate11$107$10
Hydrochlorothiazide12$101$8

2020: 6 drugs

Part D drugs prescribed in 2020
Atorvastatin34$582$17
Levothyroxine17$463$27
Potassium Chloride13$345$27
Amlodipine Besylate28$213$8
Famotidine11$123$11
Alendronate13$82$6

2019: 10 drugs

Part D drugs prescribed in 2019
Advair Diskus13$5,162$397
Levothyroxine17$553$33
Atorvastatin22$492$22
Duloxetine15$405$27
Amlodipine Besylate35$333$10
Potassium Chloride14$329$23
Gabapentin13$317$24
Bupropion Xl14$311$22
Methadone11$157$14
Omeprazole11$155$14

2018: 9 drugs

Part D drugs prescribed in 2018
Chlorthalidone16$723$45
Metoprolol19$452$24
Levothyroxine23$449$20
Atorvastatin28$367$13
Bupropion Xl13$328$25
Clopidogrel13$236$18
Potassium Chloride13$219$17
Amlodipine Besylate34$204$6
Benazepril13$112$9

2017: 9 drugs

Part D drugs prescribed in 2017
Levothyroxine31$607$20
Chlorthalidone13$540$42
Metoprolol15$443$30
Atorvastatin25$323$13
Amlodipine Besylate34$188$6
Simvastatin14$122$9
Methadone11$109$10
Famotidine14$43$3
Atenolol17$24$1

2016: 9 drugs

Part D drugs prescribed in 2016
Atrovent Hfa12$3,645$304
Atorvastatin31$712$23
Levothyroxine35$624$18
Metoprolol11$299$27
Amlodipine Besylate36$186$5
Losartan14$164$12
Metformin12$130$11
Lisinopril11$91$8
Atenolol20$65$3

2015: 8 drugs

Part D drugs prescribed in 2015
Advair Diskus11$3,362$306
Atorvastatin24$833$35
Levothyroxine25$669$27
Amlodipine Besylate15$174$12
Metformin17$109$6
Atenolol19$72$4
Simvastatin11$68$6
Hydrochlorothiazide12$56$5

2014: 8 drugs

Part D drugs prescribed in 2014
Atorvastatin17$588$35
Levothyroxine19$371$20
Lisinopril25$210$8
Amlodipine Besylate11$139$13
Omeprazole17$133$8
Paroxetine11$132$12
Atenolol18$82$5
Hydrochlorothiazide24$76$3

2013: 10 drugs

Part D drugs prescribed in 2013
Valacyclovir12$879$73
Atorvastatin17$868$51
Proair Hfa14$660$47
Buspirone11$650$59
Metformin15$285$19
Benazepril-Hydrochlorothiazide11$252$23
Levothyroxine14$208$15
Lisinopril23$179$8
Atenolol32$152$5
Hydrochlorothiazide35$117$3

Professional record

NPI
1578605523
Licence
CA A55883California A55883: Current · expires 2027-09-30
Trained
Stanford University School of Medicine, 1994
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Family medicine (207Q00000X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2007-02-13
NPI last updated
2024-04-16
NPI record certified
2024-04-16

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 211 Quarry Rd # N329, Palo Alto, CA, 94304